433 related articles for article (PubMed ID: 16581346)
21. Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing.
Siegmund D; Wicovsky A; Schmitz I; Schulze-Osthoff K; Kreuz S; Leverkus M; Dittrich-Breiholz O; Kracht M; Wajant H
Mol Cell Biol; 2005 Aug; 25(15):6363-79. PubMed ID: 16024776
[TBL] [Abstract][Full Text] [Related]
22. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells.
Langaas V; Shahzidi S; Johnsen JI; Smedsrød B; Sveinbjørnsson B
Anticancer Res; 2001; 21(6A):3733-8. PubMed ID: 11911240
[TBL] [Abstract][Full Text] [Related]
25. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
[TBL] [Abstract][Full Text] [Related]
26. TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death.
Miura Y; Tsujioka T; Nishimura Y; Sakaguchi H; Maeda M; Hayashi H; Dong M; Hyodoh F; Yata K; Wada H; Sugihara T; Otsuki T
Anticancer Res; 2006; 26(6B):4115-24. PubMed ID: 17201122
[TBL] [Abstract][Full Text] [Related]
27. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis.
Palao G; Santiago B; Galindo M; Payá M; Ramirez JC; Pablos JL
Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.
Xu X; Fu XY; Plate J; Chong AS
Cancer Res; 1998 Jul; 58(13):2832-7. PubMed ID: 9661898
[TBL] [Abstract][Full Text] [Related]
31. MAP kinase subtypes and Akt regulate diosgenin-induced apoptosis of rheumatoid synovial cells in association with COX-2 expression and prostanoid production.
Liagre B; Leger DY; Vergne-Salle P; Beneytout JL
Int J Mol Med; 2007 Jan; 19(1):113-22. PubMed ID: 17143555
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL.
Ganten TM; Koschny R; Haas TL; Sykora J; Li-Weber M; Herzer K; Walczak H
Hepatology; 2005 Sep; 42(3):588-97. PubMed ID: 16037944
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
Baader E; Toloczko A; Fuchs U; Schmid I; Beltinger C; Ehrhardt H; Debatin KM; Jeremias I
Cancer Res; 2005 Sep; 65(17):7888-95. PubMed ID: 16140959
[TBL] [Abstract][Full Text] [Related]
34. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis.
Jüngel A; Baresova V; Ospelt C; Simmen BR; Michel BA; Gay RE; Gay S; Seemayer CA; Neidhart M
Ann Rheum Dis; 2006 Jul; 65(7):910-2. PubMed ID: 16284094
[TBL] [Abstract][Full Text] [Related]
35. p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes.
Lee J; Shin JS; Park JY; Kwon D; Choi SJ; Kim SJ; Choi IH
J Neurosci Res; 2003 Dec; 74(6):884-90. PubMed ID: 14648593
[TBL] [Abstract][Full Text] [Related]
36. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
37. Enhanced susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in oral squamous cell carcinoma cells treated with phosphatidylinositol 3-kinase inhibitors.
Uchida M; Iwase M; Takaoka S; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 May; 30(5):1163-71. PubMed ID: 17390018
[TBL] [Abstract][Full Text] [Related]
38. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
[TBL] [Abstract][Full Text] [Related]
39. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
40. Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner.
Yanase N; Kanetaka Y; Mizuguchi J
Oncol Rep; 2007 Oct; 18(4):1031-8. PubMed ID: 17786370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
